跳至主要内容
临床试验/CTRI/2017/10/010125
CTRI/2017/10/010125已完成未知

Multi-centric Study for Screening and detection of oral potentially malignant disorders (OPMD) non-invasively by fluorescence and diffuse reflectance imaging with OralScan camera, and development of an algorithm for tissue discrimination

Sascan Meditech Pvt Ltd0 个研究点目标入组 336 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
336

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients presenting with oral potentially malignant disorder (OPMD) lesions such as leukoplakia, erythroplakia, oral sub mucous fibrosis (OSMF), dysplasia and moderate to well differentiate squamous cell cancer.
  • 2.Healthy Volunteers without tobacco/pan/gutka/arrecanut/cigarette or beedi smoking/alcohol habits and any visible symptoms of other diseases or tissue inflammation in the oral cavity

排除标准

  • 1.Previous treatments for cancer.
  • 2.Patients with systemic conditions that contraindicates biopsy.
  • 3.Recent application of any medication orally for at least four weeks.
  • 4.Patients not willing to participate

研究者

发起方
Sascan Meditech Pvt Ltd

相似试验